March 24, 2022
Are we learning yet?
As the first quarter comes to a close things are about to get very interesting in the diabetes device space. Here are some keys to what’s coming-
1. Now that Dexcom has received the CE mark for the G7 FDA approval should come anytime now.
2. Insulet is rolling out the OmniPod 5
3. THE WORLD IS RETURNING TO “NORMAL”
It’s point number 3 that’s most important. While none of us know what this new normal will really be like the fact is patients can now return to their past habits. This includes being able . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.
